Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuankai Shi

Showing results (31-40 of 347) with videos related to

Pageof 35
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 21, 2012
[Efficacy of pemetrexed as second-line therapy or beyond in patients with advanced non-small cell lung cancer]Junling Li, Jing Wang, Xuezhi Hao, et al.
Scandinavian Journal of Immunology|September 20, 2019
Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysisShuxia Liu, Qiaoyun Tan, Yuanyuan Song, et al.
Asia-Pacific Journal of Clinical Oncology|March 10, 2017
Efficacy of icotinib in lung squamous-cell cancer: A real-world experience from single institutionJianping Xu, Xiaoyan Liu, Sheng Yang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 24, 2011
[Effect of rs2293347 Polymorphism in EGFR on the Clinical Efficacy of Gefitinib 
in Patients with Non-small Cell Lung Cancer]Fei Ma, Binghe Xu, Dongxin Lin, et al.
Oncotargets and Therapy|October 28, 2017
Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective studyJianping Xu, Xiaoyan Liu, Sheng Yang, et al.
Leukemia|October 30, 2020
Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advancesTingyu Wen, Jinsong Wang, Yuankai Shi, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 15, 2026
[Chinese Expert Consensus on Diagnosis and Treatment of Non-small Cell Lung Cancer with MET Abnormality (2026 Version)]Jun Chen, Baohui Han, Yi Hu, et al.
Zhonghua Yi Xue Za Zhi|July 23, 2002
[Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor]Yuankai Shi, Xiaohong Han, Xiaohui He, et al.
Plos One|March 6, 2014
Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenograftsShuai Wang, Xiaohong Han, Jianfei Wang, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 studyTongji Xie, Guangyu Fan, Le Tang, et al.
Pageof 35

Showing results (31-40 of 347) with videos related to

Sort By:
Pageof 35
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 21, 2012
[Efficacy of pemetrexed as second-line therapy or beyond in patients with advanced non-small cell lung cancer]Junling Li, Jing Wang, Xuezhi Hao, et al.
Scandinavian Journal of Immunology|September 20, 2019
Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysisShuxia Liu, Qiaoyun Tan, Yuanyuan Song, et al.
Asia-Pacific Journal of Clinical Oncology|March 10, 2017
Efficacy of icotinib in lung squamous-cell cancer: A real-world experience from single institutionJianping Xu, Xiaoyan Liu, Sheng Yang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 24, 2011
[Effect of rs2293347 Polymorphism in EGFR on the Clinical Efficacy of Gefitinib 
in Patients with Non-small Cell Lung Cancer]Fei Ma, Binghe Xu, Dongxin Lin, et al.
Oncotargets and Therapy|October 28, 2017
Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective studyJianping Xu, Xiaoyan Liu, Sheng Yang, et al.
Leukemia|October 30, 2020
Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advancesTingyu Wen, Jinsong Wang, Yuankai Shi, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 15, 2026
[Chinese Expert Consensus on Diagnosis and Treatment of Non-small Cell Lung Cancer with MET Abnormality (2026 Version)]Jun Chen, Baohui Han, Yi Hu, et al.
Zhonghua Yi Xue Za Zhi|July 23, 2002
[Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor]Yuankai Shi, Xiaohong Han, Xiaohui He, et al.
Plos One|March 6, 2014
Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenograftsShuai Wang, Xiaohong Han, Jianfei Wang, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2024
Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 studyTongji Xie, Guangyu Fan, Le Tang, et al.
Pageof 35